lobbying_activities: 2982334

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2982334	fbd2134b-e410-4d1c-9912-a52de6801003	Q1	ARKEMA INC. AND ITS AFFILIATES (FKA ARKEMA INC.)	13370	ARKEMA INC. AND ITS AFFILIATES (FKA ARKEMA INC.)	2023	first_quarter	CHM	Toxic Substances Control Act (TSCA) implementation, including new and existing chemicals regulations and new chemicals approvals and other chemical regulations, including remediation, superfund and other issues. Issues related to fluorochemicals, fluoropolymers, hydrofluorocarbons, and/or Montreal Protocol (including the Kigali Amendment) and/or the Paris Agreement Significant New Alternatives Policy program regulations. Issues and legislation related to per- and polyfluoroalkyl substances/materials General chemical manufacturing issues, 3D printing issues and research and development issues	Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,SENATE		270000	0	0	2023-04-20T13:49:13-04:00